Gijtenbeek, R. G. P., Damhuis, R. A. M., Groen, H. J. M., van der Wekken, A. J., & van Geffen, W. H. (2020). Nationwide Real-world Cohort Study of First-line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer. Clinical lung cancer, 21(6), E647-E653. https://doi.org/10.1016/j.cllc.2020.05.019

Cui, X., Heuvelmans, M. A., Fan, S., Han, D., Zheng, S., Du, Y., Zhao, Y., Sidorenkov, G., Groen, H. J. M., Dorrius, M. D., Oudkerk, M., de Bock, G. H., Vliegenthart, R., & Ye, Z. (2020). A Subsolid Nodules Imaging Reporting System (SSN-IRS) for Classifying 3 Subtypes of Pulmonary Adenocarcinoma. Clinical lung cancer, 21(4), 314-+. https://doi.org/10.1016/j.cllc.2020.01.014

van der Linden, N., Bongers, M. L., Coupe, V. M. H., Smit, E. F., Groen, H. J. M., Welling, A., Schramel, F. M. N. H., & Uyl-de Groot, C. A. (2017). Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands. Clinical lung cancer, 18(5), e341-e347. https://doi.org/10.1016/j.cllc.2015.11.011

Pore, M., Meijer, C., de Bock, G. H., Boersma-van Ek, W., Terstappen, L. W. M. M., Groen, H. J. M., Timens, W., Kruyt, F. A. E., & Hiltermann, T. J. N. (2016). Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer. Clinical lung cancer, 17(6), 535-542. https://doi.org/10.1016/j.cllc.2016.05.015

Kuiper, J. L., Heideman, D. A. M., Wurdinger, T., Grunberg, K., Groen, H. J. M., & Smit, E. F. (2015). Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment. Clinical lung cancer, 16(1), 60-66. https://doi.org/10.1016/j.cllc.2014.07.008

Stigt, J. A., Uil, S. M., Oostdijk, A. H., Boers, J. E., van den Berg, J-W. K., & Groen, H. J. M. (2012). A Diagnostic Program for Patients Suspected of Having Lung Cancer. Clinical lung cancer, 13(6), 475-481. https://doi.org/10.1016/j.cllc.2012.03.001

de Jong, W. K., Fidler, V., & Groen, H. J. M. (2007). Prognostic classification with laboratory parameters or imaging techniques in small-cell lung cancer. Clinical lung cancer, 8(6), 376-381.

Ferrer, M., Span, S. W., Vischioni, B., Oudejans, J. J., van Diest, P. J., de Winter, J. P., Giaccone, G., & Kruyt, F. A. E. (2005). FANCD2 expression in advanced non-small-cell lung cancer and response to platinum-based chemotherapy. Clinical lung cancer, 6(4), 250-254. https://doi.org/10.3816/CLC.2005.n.005

Fokkema, E., Groen, H., Meijer, C., Timens, W., de Jong, S., & de Vries, L. (2002). The role of apoptosis-related genes in non-small-cell lung cancer. Clinical lung cancer, 4(3), 174-182. https://doi.org/10.3816/CLC.2002.n.025